Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Cenersen

EU orphan designation number: EU/3/08/587   
Active ingredient: Cenersen
Indication: Treatment of chronic lymphocytic leukaemia
Sponsor: EleosInc Limited
199 Bishopsgate, London EC2M 3UT, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/12/2008 Centralised Orphan - Designation EMEA/OD/054/08 (2008)8092 of 03/12/2008
08/07/2014 Centralised Orphan - Change of address